AVEO Pharmaceuticals, Inc. CEO Tuan Ha-Ngoc Receives Ernst & Young New England Entrepreneur of the Year(R) Award

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced that its president and chief executive officer, Tuan Ha-Ngoc, has been awarded the Ernst & Young New England Entrepreneur of the Year® in the life sciences category.

MORE ON THIS TOPIC